Category: Clinical Trials

As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31, 2025,

The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the Clinical

Psychiatric treatment is undergoing a profound shift as once-stigmatized psychedelic drugs gain mainstream acceptance. For instance, the Food and Drug Administration (FDA) approved a variant

Adding to research suggesting that vaccines for certain viral diseases may make someone less vulnerable to dementia later in life, a recent study demonstrates an association between

Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children living

A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants who

In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription costs

In 2018 the word “hangry,” the portmanteau of hungry and angry, was finally added to the Oxford English Dictionary. We say finally because the concept

Russia’s invasion of Ukraine is causing what the Financial Times called a “many-sided economic shock,” sending global prices sky-high for goods ranging from fuel to

Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including bradykinesia (slowed movement and loss of spontaneous movement), muscular rigidity, resting tremors and postural

When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If certain

Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved for

In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug development.